GlassScriptPhysician profile
Daniel B Channell
NPI 1699749044
$953.08
in general payments reported to CMS, 2019-2025
19 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.42 · 2021: $302 · 2022: $46.55 · 2023: $62.98 · 2024: $143 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $264.20 | 2021 | |
| Revance Therapeutics, INC. | $144.55 | 2025 | Daxxify |
| Abbvie INC. | $91.85 | 2019-2024 | |
| Astellas Pharma US INC | $46.26 | 2024 | Veozah |
| Organon LLC | $44.50 | 2022-2023 | Nexplanon |
| Sage Therapeutics, LLC | $42.33 | 2024 | |
| Dexcom, INC. | $40.16 | 2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $38.31 | 2025 | Myfembree |
| Avion Pharmaceuticals | $38.14 | 2021 | |
| Mayne Pharma Commercial LLC | $37.78 | 2024-2025 | |
| Shield Therapeutics INC | $31.91 | 2023 | Accrufer |
| Pfizer INC. | $25.36 | 2022 | |
| Coopersurgical, INC. | $25.29 | 2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $17.07 | 2025 | |
| Lupin INC. | $16.66 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.26 | 2025 | Thinprep 2000 Processor |
| Evofem Biosciences, INC. | $14.04 | 2025 | Phexxi, Solosec, Phexx |
| Allergan, INC. | $12.65 | 2019 | |
| Aspira Women'S Health INC | $7.76 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Channell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.